A Phase I, Single-center, Single-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral AZD1979 After Single-ascending Doses in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 11 Aug 2014
At a glance
- Drugs AZD 1979 (Primary)
- Indications Unspecified
- Focus Adverse reactions
- Sponsors AstraZeneca
- 28 Jul 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 02 Apr 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 05 Mar 2014 New trial record